Regenxbio Inc
RGNX
$7.41+0.14%
Delayed · as of Sep 28, 2026, 1:30 PM ET
Mkt cap
$440.40M
EV/Sales
2.38
P/E ratio
N/A
FY2025 Revenue
$170.44M
EPS (TTM)
$-3.78
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-113.75%
Beta
1.09
Div yield
N/A
Sector
Healthcare
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported RGNX revenue for 2025-12-31 was $170.4M. Net income was -$193.9M. Revenue was up 104.5% from 2024-12-31 to 2025-12-31. RGNX currently screens at market cap $440.4M.
Use this RGNX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RGNX income, balance, and cash tables.
Regenxbio Inc (RGNX) is a biotechnology company in the Healthcare sector.
Latest cached Regenxbio Inc (RGNX) revenue for Dec 31, 2025 was $170.4M. Net income was -$193.9M. Statements: https://lician.com/financials/rgnx
Regenxbio Inc (RGNX) market capitalization is $440.4M on the latest cached snapshot.
Regenxbio Inc (RGNX) cached previous close $7.40; day range $7.17 – $7.41; volume 436,043. Session quote: https://lician.com/quote/rgnx
Regenxbio Inc (RGNX) latest cached earnings event is "RGNX earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RGNX filing is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/rgnx